Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Alder Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€9.02
07.09.17
€22.55
06.06.19
17.00%
06.06.19

buy
Takara Bio Inc.

Start price
Target price
Perf. (%)
€10.89
07.09.17
€15.00
30.01.18
18.66%
30.01.18

buy
Takara Bio Inc.

Start price
Target price
Perf. (%)
€10.89
07.09.17
€15.00
30.01.18
18.66%
30.01.18

Medigene AG

Start price
Target price
Perf. (%)
€13.58
06.09.17
€8.00
23.10.17
-5.52%
23.10.17

Medigene AG

Start price
Target price
Perf. (%)
€13.65
06.09.17
€12.30
13.09.17
-10.89%
13.09.17

buy
Insmed Inc.

Start price
Target price
Perf. (%)
€23.56
05.09.17
€26.16
06.09.17
11.22%
06.09.17

Insmed Inc.

Start price
Target price
Perf. (%)
€23.52
05.09.17
€16.24
29.12.17
20.60%
29.12.17

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€18.93
05.09.17
€25.26
06.11.17
-16.91%
06.11.17

buy
BB Biotech AG

Start price
Target price
Perf. (%)
€54.86
05.09.17
€100.00
24.01.19
14.33%
24.01.19

Insmed Inc.

Start price
Target price
Perf. (%)
€24.22
05.09.17
€11.73
13.11.17
15.49%
13.11.17

buy
Medigene AG

Start price
Target price
Perf. (%)
€13.67
05.09.17
€17.00
24.01.18
25.09%
24.01.18

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Medigene AG

Start price
Target price
Perf. (%)
€14.61
04.09.17
€38.00
25.01.19
-38.30%
25.01.19

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.04
01.09.17
€31.66
20.10.17
6.63%
20.10.17

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€32.19
01.09.17
€35.10
20.10.17
6.63%
20.10.17

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€78.28
01.09.17
€100.00
23.10.17
34.88%
23.10.17

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€453.60
01.09.17
€526.00
04.11.21
-3.53%
19.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€47.74
01.09.17
€55.00
29.12.17
13.28%
29.12.17

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€43.06
01.09.17
€49.61
29.12.17
13.28%
29.12.17

buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€616.00
01.09.17
€1,400.0
26.12.17
-34.09%
26.12.17

buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€555.63
01.09.17
€1,262.8
26.12.17
-34.09%
26.12.17

buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€27.23
01.09.17
€36.08
23.02.18
14.81%
23.02.18

Could be worthwhile Investment >10% per year
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€30.19
01.09.17
€40.00
23.02.18
14.81%
23.02.18

Could be worthwhile Investment >10% per year
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.70
31.08.17
€60.00
04.10.17
25.79%
04.10.17

buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€43.03
31.08.17
€54.12
04.10.17
25.79%
04.10.17

buy
Immune Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.12
31.08.17
€1.80
19.12.17
-50.12%
19.12.17